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There are enormous evidences and previous reports standpoint that the enzyme of glyoxylate pathway
malate synthase G (MSG) is a potential virulence factor in several pathogenic organisms, including
Brucella melitensis 16M. Where the lack of crystal structures for best candidate proteins like MSG of B.
melitensis 16M creates big lacuna to understand the molecular pathogenesis of brucellosis. In the present
study, we have constructed a 3-D structure of MSG of Brucella melitensis 16M in MODELLER with the help
of crystal structure of Mycobacterium tuberculosis malate synthase (PDB ID: 2GQ3) as template. The
stereo chemical quality of the restrained model was evaluated by SAVES server; remarkably we identiﬁed
the catalytic functional core domain located at 4th cleft with conserved catalytic amino acids, start at ILE
59 to VAL 586 manifest the function of the protein. Furthermore, virtual screening and docking results
reveals that best leadmolecules binds at the core domain pocket of MSG catalytic residues and these
ligand leads could be the best prospective inhibitors to treat brucellosis.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
An important enzyme of the glyoxylate pathway, malate syn-
thase G (MSG) which involves catalyzation and condensation
process to produce subsequent hydrolysis of acetyl-coenzyme A
(acetyl-CoA) and glyoxylate to form malate and CoA. This reaction
is part of the glyoxylate cycle, which allows certain organisms to
derive their carbon requirements from two-carbon compounds by
bypassing the two carboxylation process steps of the citric acid
cycle [1]. MSG is an important metabolic enzyme which helped in
various pathogenic bacteria through bypassing the TCA cycle ra-
ther than using glyoxylate cycle [2]. This cycle is essential for
growth on two-carbon compounds such as ethanol and acetate,
and plays an anaplerotic role in the provision of main precursors
for biosynthesis. MSG is one of the two enzymes of glyoxylate
cycle, which is essential for the persistence of many bacteria [3].
This is an important functional gene in many pathogenic aerobe
bacteria like M. tuberculosis and facultative B. melitensis 16M [4,5].
The sequence analysis of MSG of B. melitensis 16M is known to
contain two domains such as malate synthase G and beta subunit
domain that are involved in binding of acetyl-CoA and glyoxylate
and are responsible for the Brucella pathogenesis by bypassing theB.V. This is an open access article u
enkateswara University, Tir-
B. Matcha).aerobic conditions. In the present study, we modeled MSG struc-
ture of B. melitensis 16M and compared with previously de-
termined crystal structures of substrate and product complexes
from the database.
Protein modeling is a challenge in drug discovery, because
predicting the accurate 3-D structure of proteins has always been
and remains a complicated assignment [6]. In Template based
protein modeling (TBM), the accuracy of protein structures, par-
ticularly their binding sites, is essential for the success of modeling
protein complexes. Overall, approximately 50% of complexes with
their interfaces modeled by high-throughput techniques had ac-
curacy suitable for meaningful docking experiments. This per-
centage will grow with the increasing availability of co-crystallized
protein-protein complexes [7]. TBM structure prediction techni-
ques rely on the study of principles that dictate the 3-D structure
of proteins from the theory of evolution viewpoint [8], recently;
this type of modeling becomes a most popular modeling. TBM
involves several steps; identiﬁcation of homologous (templates),
alignment of target to template, structure building, reﬁnement and
validation. Moreover, as molecular docking and virtual screening
becomes more predictive and prevalent; the possibility of inter-
facing such tools with functional genomics via threading or
homology modeling becomes increasingly tempting. MSG in Bru-
cella has been reported without 3-D structure from the previous
screening reports [5]. Hence the lack of crystal structures for best
candidate protein like MSG in our previous studies continues by
predicting the 3-D structure of MSG by using comparativender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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MSG was robust by 3-D structure, evaluated, and deposited in
Protein Model Data Base (PMDB) which stores manually built 3-D
models of proteins.2. Materials and methods
2.1. Homology modeling and optimization
Homology modeling of protein MSG matures in MODELLER 9.12
by using python scripts. Protein sequence was subjected to Blast-P
against PDB to ﬁnd out suitable template for homology modeling.
The constructed model was optimized using variable target func-
tion method (VTFM) and tuned by adjusting ‘automodel.library’
schedule, ‘automodel.max’ var-iterations and ‘automodel.max’.
The molecular dynamics (MD) with simulated annealing (SA) step
was tuned by adjusting ‘automodel.md’ level with conjugate gra-
dients (CG), residue range, and energy scaling factor, and then
reﬁned with SA parameterization. The whole optimization can be
repeated multiple times if desired (by default it is run only once)
by adjusting ‘automodel.repeat’ optimization, whereas in the
present case the optimization was not attained in the ﬁrst runwith
default parameters and hence moved for the second run. The
VTFM optimization with maximum 500 iterations and MD opti-
mization with slow level mode was carried out and the whole
cycle was repeated for two times to generate an optimized con-
formation of the model with a gradients of 0.2 Å to 0.1 Å [9]. The
optimized model was evaluated by Ramachandran plot PROCHECK
(for conformations of the ψ and φ angles are possible for an
amino-acid residues in a protein), verify_3D (Determines the
compatibility of an atomic model (3D) with its own amino acid
sequence (1D), ERRAT (verifying protein structures determined by
crystallography and modeled proteins) and WHATIF (checking of
many sterochemical parameters of the residues in the model).
2.2. Molecular dynamics of MSG protein
In the anticipation of attaining the stabilized conformation of
the MSG, the structure was subjected to MD simulations in the
Discovery Studio 4.0. The software uses the standard dynamic
cascade tool. The structure was loaded into the graphical window
of Discover Studio and initially reﬁned with a two steps of energy
minimization using steepest descent and conjugate gradient al-
gorithm to an RMSD of 0.1 Å in a total of 3000 maximum steps.
The system was heated from 50 K to 300 K in 100 ps and equili-
brated for another 100 ps under constant pressure. Further the
system was progressed into production phase for 20,000 ps with
NPT ensembles under generalized born implicit solvent model. The
energy levels and RMSD were observed throughout the production
phase and the stabilized conformation was trapped and saved for
further studies.
2.3. Active site prediction
Active site prediction is necessitate to ﬁnd out the speciﬁc
functional part of the protein therefore, it seems apparent that
prediction of protein domains is crucial to understand the protein
function. Thus, 3D structural domains and active site residues
were identiﬁed by a computed atlas of surface topography of
proteins server (CASTp) [10].
2.4. Ligands screening from ZINC database
Ligands were screened from the ZINC database on the basis of
90% structural similarity of known inhibitor of MSG of M.tuberculosis i.e. 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic
acid [11]. Based on such structural resemblance, 2285 analogs
were identiﬁed and subsequently prepared as a ligand spread
sheet for further virtual screening.
2.5. Virtual screening
PyRx virtual screening software [12] was used for the virtual
screening of ligands that includes AutoDock [13] and AutoDock
Vina [14] with the Lamarckian genetic algorithm (LGA) as scoring
function. Active site dimensions were set as grid size of center
X¼54.41 Å, center Y¼30.78 Å, center Z¼79.94 Å (XYZ axis) to
dock the ligands where 10 maximum exhaustiveness was calcu-
lated for each ligand. Before initiation of docking operation,
charges were assigned to protein and ligand structures by Auto-
Dock Vina. The resulted ligands have high potential for being used
as drug candidates.
2.6. Pharmacokinetic analysis
FAFDrugs3 tool can perform computational prediction of some
ADME-Tox properties (Adsorption, Distribution, Metabolism, Ex-
cretion and Toxicity) [15] and admetSAR provides the latest and
most comprehensive manually curated data for diverse chemicals
associated with known ADMET proﬁles [16] both web servers
were used to analyze the ADMET properties of top 5 Virtual
screening hits. ADMET properties of top successive hits were
checked in optimal descriptors. Moreover the oral toxicity prop-
erties were also analyzed with this server and the probable ac-
cessorial MSG protein targets were checked for every successive
lead.3. Results
3.1. Homology modeling and optimizatio
The Blast-P results revealed a perfect reliable template, i.e.
crystal structure of a malate synthase family protein (P9WK17)
from M. tuberculosis with 2.3 Å resolutions (PDB ID: 2GQ3) shared
99% query coverage and 61% identity with 0.0 E-Value. Align 2-D
results showed a high-level sequence similarity between target
and template. Based on alignment, 100 basic models were gener-
ated for target protein by using MODELLER 9.12 comparative
modeling and the missing side chains were added and aligned
from WHATIF server.
3.2. Structure validation from all the validation servers
Structure validation SAVES results stated that homology mod-
eled protein MSG possesses reasonable 3-D structure with good
stereo-chemical quality of Ramachandran plot where PROCHECK
analysis showed most favored regions [a,b,l] with 592 residues
among 728 with 93.4% and additional allowed regions [a,b,l,p] of
39 residues with 6.2% and identiﬁed only one residue located at
disallowed regions but maximum amino acids were present in
most favored regions proven that modeled protein showing the
good reliable structure. Protein compatibility of an atomic model
(3-D) with its amino acid sequence (1-D) of window of 21 re-
sidues. verify_3D results stated that all amino acids reliable to
convert to form 3-D structure. ERRAT Error values of modeled
protein plotted as a function of the position of a sliding 9-residue
window resulted that overall quality factor with 88.88% indicating
that reliable high-resolution modeled structure.
The resultant models were sorted by discrete optimized protein
energy (DOPE) scoring function. The model number 72 (M72),
Fig. 1. Malate synthase G stereo chemical quality of the optimized protein. (A) Secondary structure of modeled protein from PyMOL. (B) The superimposition of target and
template were generated by PyMOL. (C) Verify3D of Malate synthase G modeled protein plot shows that all the residues are with positive compatibility score indicating that
they are reasonably folded. (D) ERRAT (v 2.0) values showed reasonable scores from SAVES (Structural Analysis and Veriﬁcation Server). (E) Ramachandran plot.
Fig. 2. (A) Potential Energy levels of Brucella melitensis 16M protein Malate syn-
thase G. (B) RMSD plots of protein Malate synthase G obtained from molecular
dynamics simulations showing the stabilized nature of the structure.
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ergy. Hence, we selected M72 for further studies and all amino
acid residues were shown to be at allowed regions. The protein
secondary conﬁrmation and superimposed structure with the
template are shown in (Fig. 1A and B), and the modeled protein
stereo-chemical quality and accurate results of Ramachandran plot
PROCHECK 93.4% accuracy, Protein atomic model alignment and
sequence residues 3-D-1D, verify_3D with decent alignment, Error
values of modeled protein ERRAT 88.88% results illustrated in
(Fig. 1C–E).
3.3. Molecular dynamic simulations
The validated structure of MSG was further subjected to MD
simulations to get a reliable and perfect conformation so as to
proceed for molecular docking studies. The MD results were ana-
lyzed after successful 20,000 ps of production time and it was
observed that a stabilized nature was attained at the end of the
simulation period (Fig. 2A). The potential energy levels were ob-
served where the structure showed maximum energy levels above
5000 kcal/mol and ﬂuctuated for a period of 10,000 ps and
thereafter stabilized in the further production phase around
4000 kcal/mol. Further, the RMSD plot showed that there exists
ﬂuctuation in the RMSD for a period of 17,000 ps and thereafter
stabilized around 6.5 Å (Fig. 2B). These results from MD simula-
tions showed that stabilized conformation was obtained by theend of simulation period and best suitable for further investiga-
tions and hence utilized the same for prediction of binding sites
and molecular docking studies.
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CastP active site results showed all reasonable binding pockets
of the protein model. The core domain ID 137 showed good pro-
spective active residues with area 332.8 Å2 and volume 427 Å2 for
ligand binding and functional modiﬁcations. The overall cassette
binding cleft cavity will start with ILE 69 and ends at VAL 684.
Thus, an active site of B. melitensisMSG starts from Isoleucine 69 to
Valine 586 amino acids actively involved in the binding ﬁt of lead
molecules (Fig. 3A and B). Hence, we have selected the N-terminal
binding pocket of the target protein for further docking
simulations.
3.5. Virtual screening and docking
This process involves the template modeled protein existing
ligand used as template structure and prepared ligands of reliable
lead molecules. Where the template protein contains the various
ligands coenzyme A, magnesium ion, D-malate where we had
omitted these complex ions and other molecules and selected 4-
(2-hydroxyethyl)-1-piperazine ethanesulfonic acid related ligands
screened from ZINC database. The structure, based virtualFig. 3. (A) Malate synthase secondary sequence analysis composed sheets turns, and co
functional domain region. The wire frame of malate synthase G and blue color highligh
protein malate synthase G protein domain predicted by CastP server shown as spheres. (C
protein.screening was done using 2285 structural analogs of the existing
ligand of MSG crystal structure of M. tuberculosis through Auto-
Dock Vina in PyRx software and the docking simulation energies
were determined for each ligand with 10 exhaustiveness. Root
mean square deviation (RMSD) calculations were carried out
through lamarkin geometric algorithm (LGA). Active site grid di-
mensions were set at X¼54.41 Å, Y¼30.78 Å and Z¼79.94 Å for
the center and total size dimensions were set as X¼69.23 Å,
Y¼76.35 Å and Z¼81.81 Å. All the best leads superimposed core
cavity interactions were visualized through PyMOL software
(Fig. 3C).4. Discussion
The homology model of MSG, which a key enzyme of the
glyoxylate pathway in Brucella provides valuable information to
understand its function that how the opportunistic bacterial pa-
thogens use glyoxylate pathway during pathogenesis and how
metabolic pathways employed by pathogenic bacteria during in-
fection this pathways essential for the survival of pathogens inside
the host could be helpful to develop new therapeutic strategiesils and helix turn helices and hairpins and the sequence highlighted with red box
ted region is catalytic cleft of functional domain. (B) Surface structure of modeled
) All best ligand molecules superimposed where binding at core domain of the MSG
Table 1
The 5 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid analogs showed good binding energies than 4-(2hydroxyethyl)-1-piperazine ethanesulfonic acid (positive
control). Reliable H-bond interactions with conserved motif residues and bond distances were illustrated.
Rank Ligand ID Name of compound 2D structure Binding Energy
(Kcal/Mol)
Interactions Bond length
(Å)
Protein
residues
Ligand
atoms
1 ZINC78173801 4-allyloxy-2-(2-allyloxy-2-oxo-
ethyl)-2-hydroxy-4-oxo-butanoic
7.2 Tyr81CA-N C12O6 2.89
Gln80 CA-N C12O6 3.08
Val584CA-N C11O2 3.24
2 ZINC78690149 (2R)-2-hydroxy-2-(2-hydro-
xyacetyl)-3-oxo-decanoic
7.1 Tyr81CA-N C4O4 2.94
Tyr81CA-O C12O3 2.72
Leu582C-O C9O2 2.93
Val584CA- C9O2 2.80
3 ZINC79573345 (2R)-2-[(1R)-1-hydroxypropyl]
dodecanoic
7.0 Asp78CG-OD1 C14O3 3.03
Gly80CA-N C14O3 3.15
Tyr81CA-N C14O3 3.29
Val584CA-N C15O1 3.24
4 ZINC79646184 (3R)-3-hydroxy-8-methoxy-8-oxo-
octanoic
6.9 Tyr81CA-O C5O5 2.87
Gln83CD-NE2 C8O4 3.12
Ser487CB-OG C9O3 2.94
Val584CA-N C8O2 3.04
5 ZINC79673354 (2S,4S)-2,4-dihydroxy-2-octadeca-
noyl-3-oxo-henicosanoic
6.9 Val584CA-O C35O2 2.80
Val586C-O C38O2 2.83
Val586C-O C38O4 2.89
Ala587C-O C38O4 3.07
6 ZINC78283617 (positive
control)
4-(2-hydroxyethyl)-1-piperazine
ethanesulfonic acid
6.8 Tyr81C-O C10O2 2.89
Gln83CD-NE2 C8O3 3.03
Leu582C-O C3O3 2.99
Val584CA-N C9O4 3.09
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amino acid GLU 5, in disallowed region, and all amino acids were
present in most favored regions. The other parameters such as
protein error values from ERRAT showed an increased quality
factor of 88.88% after optimization, and Verify_3D showed a
compatibility score above zero (92.46% 3D–1D values) indicating
that the protein contains favored side chain environments and
good fold regions. The robust modeled of Brucella MSG is a huge
protein composed of 728 amino acids consisting 7 sheets, 4 beta
alpha-beta units, 10 beta hairpins, 9 beta bulges, 26 strands, 33
helices, 50 helix-helix interactions, 55 beta turns and 8 gamma
turns (Fig. 3A). Among 10 different clefts of the structure, the 4th
cleft is considered as conserved with 10.54 Å average depths and is
located from ILE 69 to 586 VAL which is forming the functional
domain of the structure (Fig. 3B). The amino acids such as ASP 72,
SER 474, GLU 476, TYR 73, THR 473, and SER 583 were found to be
playing a catalytic role by forming inter-molecular interactions
with the ligands. Recent reports evidenced that glyoxylate shunt
enzymes have been implicated as virulence factors in several dif-
ferent pathogens such as M. tuberculosiss [17–19], C. albicans [20]and P. aeruginosa [21]. All these results strongly encouraging the
protein model as good and more reliable target for the docking
studies.
Thus in silico approaches have been developed as an important
part of several drug discovery programmes, from lead ﬁnding to its
optimization [22–24]; methodologies such as ligand or targeted
based computational screening [25] procedures are broadly used
in many drug discovery studies. Molecular docking procedures
were utilized in the current study to predict how small molecules
bind to MSG structure and also optionally enabled to model
binding parameters of ligand with a number of distinct con-
formational clusters and to ﬁnd all possible minimum binding
energy. PyRx virtual screening was used to screen libraries of
compounds against best potential drug target of B. melitensis 16M.
In the present study, M. tuberculosis malate synthase family pro-
tein (PDB: 2GQ3) was selected as a template to build the model
Brucella MSG structure (accession number: NP_539297.1). More-
over, a ligand 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic
acids present within the active site of 2GQ3 structure paved clues
to identify its analogs from Zinc database and used for virtual
Fig. 4. The predicted docking simulations of leads with the target protein based on lamarkin geometric algorithm and PyRx analyses: the ﬁve best leads were compared with
positive control which include (A) 4-allyloxy-2-(2-allyloxy-2-oxo-ethyl)-2-hydroxy-4-oxo-butanoic (ZINC78173801), (B) (2R)-2-hydroxy-2-(2-hydroxyacetyl)-3-oxo-de-
canoic (ZINC78690149), (C) (2R)-2-[(1R)-1-hydroxypropyl] dodecanoic (ZINC79573345), (D) (3R)-3-hydroxy-8-methoxy-8-oxo-octanoic (ZINC79646184), (E) (2S, 4S)-2,4-
dihydroxy-2-octadecanoyl-3-oxo-henicosanoic (ZINC79673354) and (F) 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid (ZINC78283617) (positive control). These leads
are showing good H-bond interactions that are indicated with yellow dashed lines. The superimposition of above leads was distributed in only N-terminal region shown as
surface with purple sticks and polar contrasts with yellow dashed lines.
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lead optimization in PyRx which include Open Bable, ligand en-
ergy minimization interface with UFF (United Force Field) with a
limit of 500 iterations for each ligand. The energy-minimized li-
gands were converted into AutoDock ligand format and prepared
as a data-set (a).
The virtual screening of 4-(2-Hydroxyethyl)-1-piperazine ethane-
sulfonic acid related analogs screened from ZINC database revealed
that, 2285 compounds with 90% similarity cut off screens and prepared
ligand spreadsheets, and from among that only ﬁve compounds
showed best afﬁnity with positive control i.e. 4-(2-hydroxyethyl)-1-
piperazine ethanesulfonic acid. The ligands 4-allyloxy-2-(2-allyloxy-2-
oxo-ethyl)-2-hydroxy-4-oxo-butanoic (ZINC78173801), (2R)-2-hydro-
xy-2-(2-hydroxyacetyl)-3-oxo-decanoic (ZINC78690149), (2R)-2-[(1R)-
1-hydroxypropyl] dodecanoic (ZINC79573345), (3R)-3-hydroxy-8-
methoxy-8-oxo-octanoic (ZINC79646184) and (2S,4S)-2,4-dihydroxy-
2-octadecanoyl-3-oxo-henicosanoic (ZINC79673354) showed the
binding afﬁnities of 7.2, 7.1, 7.0, 6.9 and 6.9 (Kcal/Mol) re-
spectively, and 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid
(ZINC78283617) showed 6.8 (kcal/Mol) respectively. Docking results
and hydrogen bond interactions with these ligands and their bond
angles, bond lengths and atoms involved in these interactions were
analyzed and illustrated in (Table 1). The complete core site analysis
also revealed that all the leads have the ability to interact with 132
amino acid residues were considered as binding pocket loop. From the
complete core binding pocket catalytic amino acid residues thatactively participated in the interaction with the best ligand molecules
were as follows ILE 69, ASP 70, TRP 72, TYR 73, THR 473, SER 474, GLU
476, ALA 477, LEU582, SER 583 and VAL 586 by means of C——O, O——
H, N——O, N——H, CA——N atoms. The hydrogen bond formation was
majorly observed among all the analogs with almost equal bond dis-
tances. 4-allyloxy-2-(2-allyloxy-2-oxo-ethyl)-2-hydroxy-4-oxo-buta-
noic (ZINC78173801), (2R)-2-hydroxy-2-(2-hydroxyacetyl)-3-oxo-de-
canoic (ZINC78690149), (2R)-2-[(1R)-1-hydroxypropyl] dodec-
anoic (ZINC79573345), (3R)-3-hydroxy-8-methoxy-8-oxo-octanoic
(ZINC79646184) and (2S,4S)-2,4-dihydroxy-2-octadecanoyl-3-oxo-he-
nicosanoic (ZINC79673354) showed three, four, six and two hydrogen
bond interactions respectively. Residues such as ASP 72, GLY 80, TYR
81, VAL 584 with 4-allyloxy-2-(2-allyloxy-2-oxo-ethyl)-2-hydroxy-4-
oxo-butanoic, TYR 81, LEU 582 and VAL584 with (2R)-2-hydroxy-2-(2-
hydroxyacetyl)-3-oxo-decanoic, (2R)-2-[(1R)-1-hydroxypropyl] dode-
canoic with GLY 80, TYR 81, and VAL 584, (3R)-3-hydroxy-8-methoxy-
8-oxo-octanoic with TYR 81, GLN 83, SER 474, VAL 584, and (2S,4S)-
2,4-dihydroxy-2-octadecanoyl-3-oxo-henicosanoic with VAL 586, VAL
584 and ALA 587 sequence residues were associated with the hydro-
gen bond formation. Moreover, all the above 4-(2-hydroxyethyl)-1-pi-
perazine ethanesulfonic acid analogs showed reliable afﬁnities with
MSG protein (Fig. 4A–F). Other active site amino acid residues were
observed to participate in the formation of hydrophobic interactions
with ligands. All these interactions reﬂected a good afﬁnity levels
among the target and ligands than with the positive control 4-(2-hy-
droxyethyl)-1-piperazine ethanesulfonic acid (Fig. 4F).
Table 2
(A) FAF-Drugs3 results tabulated for top 5 successive hits and of control ligand ZINC78283617. (B) admetSAR toxicity results of top 5 successive hits and of control ligand
ZINC78283617 ligand virtual screening data.
T2. A FAF-Drugs3 results
S.No Property ZINC78173801 ZINC78690149 ZINC79573345 ZINC79646184 ZINC79673354 ZINC78283617
1. Log P 0.07 1.17 5.26 0.00 15.46 1.65
2. Log aqueous solubility
(SW)(dm3)
0.76 1.53 3.96 0.58 5.17 1.87
3. Molecular Weight (kDa) 272.25 260.28 258.40 204.22 439.00 202.25
4. H Bond donors 1 2 1 1 2 2
5. H Bond Acceptors 7 6 3 5 6 4
6. Solubility(mg/l) 127595.82 56312.33 4906.87 114552.52 11906.87 31188.76
7. Oral Bioavailability
(VEBER)
Good Good Good Good Good Good
8. Oral Bioavailability (EGAN) Good Good Good Good Good Good
9. Phospo lipidosis NonInducer NonInducer NonInducer NonInducer NonInducer NonInducer
10 Status Accepted Accepted Accepted Accepted Accepted Accepted
T2. B admetSAR toxicity
1. Blood-Brain Barrier BBBþ BBBþ BBBþ BBBþ BBBþ BBBþ
2. Human Ether-a-go-go-Re-
lated Gene Inhibition
Weak inhibitor Weak inhibitor Weak inhibitor Weak inhibitor Weak inhibitor Weak inhibitor
Non-inhibitor Non-inhibitor Non-inhibitor Non-inhibitor Non-inhibitor Non-inhibitor
3. AMES Toxicity Non AMES toxic Non AMES toxic Non AMES toxic Non AMES toxic Non AMES toxic Non AMES toxic
4. Carcinogens Non-carcinogens Non-carcinogens Non-carcinogens Non-carcinogens Non-carcinogens Non-carcinogens
5. Fish Toxicity High FHMT High FHMT High FHMT High FHMT High FHMT High FHMT
6. Tetrahymena pyriformis
Toxicity
High TPT High TPT High TPT High TPT High TPT High TPT
7. Biodegradation Not ready
biodegradable
Ready
biodegradable
Ready
biodegradable
Ready
biodegradable
Ready
biodegradable
Ready
biodegradable
8. Acute Oral Toxicity III III III III III III
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and efﬁcient ADMET properties. A comparative oral toxicity
property analysis was carried out for the above best 5 lead mo-
lecules against positive control to conﬁne FAFdrugs3 and ad-
metSAR toxic properties. The Lipinski rule of ﬁve deﬁnes four
simple physicochemical parameter ranges of orally active com-
pounds like molecular weight; log-P, H-bond donors and H-bond
acceptors (MWT_500, logP_5, H-bond donors_5, and H-bond ac-
ceptors_10) (Table 2A). So, prediction of drug-like non-toxic
compounds is an important for modern drug discovery which are
mainly obtained from the repositories of the modern drug data
report (MDDR), comprehensive medicinal chemistry (CMC) and
Derwent word drug index (WDI) [26,27]. Herein, the 4-(2-hydro-
xyethyl)-1-piperazine ethanesulfonic acid and best 5 lead com-
pounds tested their non-toxic and druggability nature were
identiﬁed based on the rule of ﬁve predictions like Blood-Brain
Barrier, AMES Toxicity, carcinogens, acute oral toxicity from ad-
metSAR results showed best druggability nature (Table 2B). The
proposed 5 inhibitors with drug-like properties against the target
were further optimized along with non-oral toxicity with con-
ﬁrmatory results (Table 2A). These results were strongly suggest-
ing towards in vitro and in vivo further investigations to prove
their potential as anti-brucellosis agents.5. Conclusion
In conclusion we selected MSG as a target protein, further, its
modeling studies followed by structure based virtual screening
using PyRx AutoDock Vina, helped to identify ﬁve best potential
inhibitors i.e. 4-allyloxy-2-(2-allyloxy-2-oxo-ethyl)-2-hydroxy-4-
oxo-butanoic (ZINC78173801), (2R)-2-hydroxy-2-(2-hydro-
xyacetyl)-3-oxo-decanoic (ZINC78690149), (2R)-2-[(1R)-1-hydro-
xypropyl] dodecanoic (ZINC79573345), (3R)-3-hydroxy-8-meth-
oxy-8-oxo-octanoic (ZINC79646184) and (2S,4S)-2,4-dihydroxy-2-
octadecanoyl-3-oxo-henicosanoic (ZINC79673354) which showedgood binding orientations and strong afﬁnities within the active
site. Furthermore, in vivo studies are required to evaluate the
prospective drug activity and efﬁcacy of the proposed leads
against MSG. Thus, the in silico strategies adopted in the present
methodologies are standard where reduces time and the cost with
a safe and effective. And these drugs prior to further the clinical
trials. The present study we proposed ﬁve best effective inhibitors
of Brucella MSG protein, and provide a root line to understand
protein, ligand molecular interactions in drug discovery process to
treat the Brucella infections.Acknowledgments
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